Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphoblastic Leukemia Ph Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03512405
What this trial is testing

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
CD19 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+1 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)UnknownNCT04688983
What this trial is testing

Study in Adult Ph-positive ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
Cardiff University 180
Testing effectiveness (Phase 2)UnknownNCT05466175
What this trial is testing

Olverembatinib in the Treatment of Ph+ ALL

Who this might be right for
Philadelphia-Positive ALL
Chen Suning 55
Early research (Phase 1)Looking for participantsNCT07250087
What this trial is testing

Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute 36
Testing effectiveness (Phase 2)Study completedNCT01460160
What this trial is testing

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Pediatric
Bristol-Myers Squibb 106
Not applicableLooking for participantsNCT07493161
What this trial is testing

Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL

Who this might be right for
Ph+ ALL
Institute of Hematology & Blood Diseases Hospital, China 110
Not applicableNo Longer AvailableNCT04559555
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443488
What this trial is testing

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Who this might be right for
HSCTPh+ ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Ended earlyNCT03698552
What this trial is testing

ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Blasts 5 Percent or More of Bone Marrow Nucleated CellsCD22 PositivePhiladelphia Chromosome Positive+2 more
M.D. Anderson Cancer Center 37
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Early research (Phase 1)Looking for participantsNCT04260022
What this trial is testing

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Who this might be right for
Leukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more
Ascentage Pharma Group Inc. 242
Large-scale testing (Phase 3)Looking for participantsNCT06051409
What this trial is testing

Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Who this might be right for
Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc. 350
Early research (Phase 1)Study completedNCT00316953
What this trial is testing

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00298987
What this trial is testing

Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate

Who this might be right for
Leukemia, Myeloid, ChronicLeukemia, Lymphocytic, Acute, L2
Bristol-Myers Squibb 400
Testing effectiveness (Phase 2)Study completedNCT01445080
What this trial is testing

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Blastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT01030718
What this trial is testing

Rollover Study of BMS-354825 in Patients With CML and Ph+ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Bristol-Myers Squibb 54
Early research (Phase 1)Study completedNCT00940524
What this trial is testing

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00750659
What this trial is testing

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation
Sheba Medical Center 24
Not applicableUnknownNCT01185886
What this trial is testing

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,200
Next Page